INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Rescheduling of Con Call Meeting29-01-2022
29-01-2022
INDOCO REMEDIES LTD. - 532612 - Schedule Of Con Call Meeting
Schedule of Con Call Meeting25-01-2022
Indoco Remedies Q3 PAT seen up 54.9% YoY to Rs 39.3 cr: Prabhudas Lilladher
Net Sales are expected to increase by 17.1 percent Y-o-Y (up 0.6 percent Q-o-Q) to Rs 389.2 crore, according to Prabhudas Lilladher.13-01-2022
INDOCO REMEDIES LTD. - 532612 - Shareholding for the Period Ended December 31, 2021
Indoco Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here11-01-2022
INDOCO REMEDIES LTD. - 532612 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- JAYSHANKAR MENONDesignation :- Company Secretary and Compliance Officer06-01-2022
INDOCO REMEDIES LTD. - 532612 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
CERTIFICATE UNDER REG 74(5) OFSEBI (DP) REGULATIONS, 201806-01-2022
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Board Meeting Notice05-01-2022
INDOCO REMEDIES LTD. - 532612 - Board Meeting Intimation for -Unaudited Financial Results For The Quarter Ended 31-12-2021
INDOCO REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2022 ,inter alia, to consider and approve Unaudited Financial Results for the quarter ended 31-12-202104-01-2022
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investors Meet23-12-2021